These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 18190691)
1. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells. Pan Y; Weinman EJ; Dai JL Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691 [TBL] [Abstract][Full Text] [Related]
2. NHERF1: molecular brake on the PI3K pathway in breast cancer. Georgescu MM Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260 [TBL] [Abstract][Full Text] [Related]
4. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599 [TBL] [Abstract][Full Text] [Related]
5. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling. Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959 [TBL] [Abstract][Full Text] [Related]
6. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation. Molina JR; Morales FC; Hayashi Y; Aldape KD; Georgescu MM Cancer Res; 2010 Sep; 70(17):6697-703. PubMed ID: 20736378 [TBL] [Abstract][Full Text] [Related]
7. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2. Jeong J; VanHouten JN; Kim W; Dann P; Sullivan C; Choi J; Sneddon WB; Friedman PA; Wysolmerski JJ J Biol Chem; 2017 Apr; 292(16):6555-6568. PubMed ID: 28235801 [TBL] [Abstract][Full Text] [Related]
8. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1). Pan Y; Wang L; Dai JL Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868 [TBL] [Abstract][Full Text] [Related]
9. Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression. Yang L; Wang Y; Chen P; Hu J; Xiong Y; Feng D; Liu H; Zhang H; Yang H; He J Endocrinology; 2011 Dec; 152(12):4537-49. PubMed ID: 21990315 [TBL] [Abstract][Full Text] [Related]
10. PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer. Conley-LaComb MK; Huang W; Wang S; Shi D; Jung YS; Najy A; Fridman R; Bonfil RD; Cher ML; Chen YQ; Kim HC Am J Pathol; 2012 Mar; 180(3):1017-1027. PubMed ID: 22209699 [TBL] [Abstract][Full Text] [Related]
11. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer. Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway. Wang F; Li L; Chen Z; Zhu M; Gu Y Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965 [TBL] [Abstract][Full Text] [Related]
14. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer. Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983 [TBL] [Abstract][Full Text] [Related]
15. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS. Sun J; Li P; Yang J Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004 [TBL] [Abstract][Full Text] [Related]
16. Alteration in the sensitivity to crizotinib by Na Yang F; Hu M; Chang S; Huang J; Si Y; Wang J; Cheng S; Jiang WG BMC Cancer; 2020 Mar; 20(1):202. PubMed ID: 32164629 [TBL] [Abstract][Full Text] [Related]
17. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane. Georgescu MM; Cote G; Agarwal NK; White CL Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762 [TBL] [Abstract][Full Text] [Related]
18. In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression. Cuello-Carrión FD; Cayado-Gutiérrez N; Natoli AL; Restall C; Anderson RL; Nadin S; Alvarez-Olmedo D; Castro GN; Gago FE; Fanelli MA; Ciocca DR Cell Stress Chaperones; 2013 Sep; 18(5):559-67. PubMed ID: 23397229 [TBL] [Abstract][Full Text] [Related]
19. Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. Fu X; Creighton CJ; Biswal NC; Kumar V; Shea M; Herrera S; Contreras A; Gutierrez C; Wang T; Nanda S; Giuliano M; Morrison G; Nardone A; Karlin KL; Westbrook TF; Heiser LM; Anur P; Spellman P; Guichard SM; Smith PD; Davies BR; Klinowska T; Lee AV; Mills GB; Rimawi MF; Hilsenbeck SG; Gray JW; Joshi A; Osborne CK; Schiff R Breast Cancer Res; 2014 Sep; 16(5):430. PubMed ID: 25212826 [TBL] [Abstract][Full Text] [Related]
20. Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling. Wheeler DS; Barrick SR; Grubisha MJ; Brufsky AM; Friedman PA; Romero G Oncogene; 2011 Jan; 30(1):32-42. PubMed ID: 20802536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]